ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
11.02
+0.27 (2.51%)
At close: Aug 6, 2026, 4:00 PM EDT
10.81
-0.21 (-1.91%)
After-hours: Aug 6, 2026, 7:34 PM EDT
ImmuCell Employees
ImmuCell had 73 employees as of December 31, 2025. The number of employees decreased by 2 or -2.67% compared to the previous year.
Employees
73
Change
-2
Growth
-2.67%
Revenue / Employee
$410,059
Profits / Employee
-$7,471
Market Cap
99.70M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Heron Therapeutics | 128 |
| Adicet Bio | 102 |
| Pelthos Therapeutics | 92 |
| Verrica Pharmaceuticals | 76 |
| Oncolytics Biotech | 29 |
| Black Diamond Therapeutics | 21 |
| Coya Therapeutics | 8 |
| Aldeyra Therapeutics | 7 |
ICCC News
- 6 hours ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026 - GlobeNewsWire
- 4 weeks ago - Immucell reports preliminary Q2 revenue $7.2M - TheFly
- 4 weeks ago - ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results - GlobeNewsWire
- 7 weeks ago - ImmuCell Slides: Investor presentation - Filings
- 2 months ago - ImmuCell Transcript: AGM 2026 - Transcripts
- 2 months ago - ImmuCell Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - ImmuCell Quarterly report: Q1 2026 - Filings
- 2 months ago - ImmuCell Earnings release: Q1 2026 - Filings